In pharmaceutical supply, documents are not paperwork for the sake of paperwork. They are the
foundation of product review, quality control, regulatory assessment, and customer approval.
When a buyer evaluates an API, intermediate, or specialty ingredient, the product itself is only
one part of the decision. The buyer must also understand how the material was manufactured,
tested, stored, documented, and released. This is where the documentation package becomes
critical.
A Certificate of Analysis helps confirm the test results for a specific batch. Specifications define
the acceptable quality standards for the material. SDS or MSDS documents support safe
handling, storage, transport, and internal safety review. GMP documentation may help customers
assess manufacturing standards. Impurity profiles, stability information, residual solvent data,
and other supporting files can also be important depending on the product and its intended use.
Documentation requirements vary by product, manufacturer, country, dosage form, and
customer qualification process. A commercial API used in a finished dosage product may require
deeper documentation than a development-stage intermediate. Similarly, materials used for
regulated markets may require different support than materials used for early-stage research or
process development.
Ventalys supports customers by helping coordinate available documentation and reviewing what
may be needed for commercial, clinical, and development-stage requirements. The goal is
simple: help buyers understand the material before it moves
